SCN2A ENCEPHALOPATHY
Clinical trials for SCN2A ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new SCN2A ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for SCN2A ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for babies with rare seizure disorder: drug trial targets SCN2A gene
Disease control Recruiting nowThis study tests a medicine called elsunersen in 40 children with a rare, severe form of epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug can safely reduce how often seizures happen over 24 weeks. Children must have started having seizures before 3 mon…
Matched conditions: SCN2A ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can mapping rare genetic variants unlock better care for autism-related disorders?
Knowledge-focused Recruiting nowThis international online study collects medical, behavioral, and developmental information from people with rare genetic changes that are linked to autism and other neurodevelopmental disorders. By partnering with families, researchers aim to build a detailed database to improve…
Matched conditions: SCN2A ENCEPHALOPATHY
Sponsor: Simons Searchlight • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC